Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
01/2008
01/09/2008EP1874747A1 Histamine h3-recept0r ligands and their therapeutic application
01/09/2008EP1440971B1 Fluorosulfonyl compounds and process for production of compounds derived therefrom
01/09/2008EP1402890B1 Sulfonamide derivatives
01/09/2008EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
01/09/2008CN101103000A Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
01/09/2008CN100360517C Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
01/09/2008CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors
01/09/2008CN100360484C Process of removing organic halogen-containing compounds
01/08/2008US7316884 5-methylene-1,3-dioxolan-4-one derivatives, process for their production, polymers of the derivatives, resist compositions, and pattern formation process
01/08/2008CA2408602C Phenylglycine derivatives
01/08/2008CA2267315C Ethylamine derivatives
01/03/2008WO2008001912A1 Substituted benzyl ester derivative and use thereof
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/02/2008EP1871759A1 Benzodioxane and benzodioxolane derivatives and uses thereof
01/02/2008EP1438280B1 Novel norbornane and norbornene derivatives, use thereof and perfumed products containing same.
01/02/2008EP1263716B1 Amino acid derivatives as hiv aspartyl protease inhibitors
12/2007
12/27/2007WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299267 Process for the production of glycerol carbonate esters
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/27/2007US20070299129 Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity
12/26/2007EP1870407A1 Process for the preparation of glycerincarbonate esters
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1870396A1 Benzyloxypropylamine derivative
12/26/2007EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007CN100357303C Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
12/26/2007CN100357288C Synthesis method for converting trans 1,3-dioxolane derivative to correspondent cis form
12/26/2007CN100357274C Diaryl-enynes
12/26/2007CN100357249C Process for production of carbonyl compounds
12/25/2007US7312241 Diphenylethylene compounds and uses thereof
12/21/2007WO2007129960A3 Novel processes for preparing intermediates of ccr antagonists
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/19/2007EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN100355746C Synthesis of 1, 4-dioxo spiro [4, 5] decane-8-one
12/13/2007WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
12/13/2007US20070287825 Constrained cis-diol-borate bioconjugation system
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/12/2007EP1863759A1 Process for preparation of bicalutamide
12/12/2007CN100354268C Novel triazolo pyrimidine compounds
12/12/2007CN100354249C Process for preparing optically active nitro compounds and cyano compounds
12/11/2007US7307185 Process for producing optically active fluorochemical
12/06/2007WO2007137738A1 Spirocyclic nitriles as protease inhibitors
12/06/2007US20070281996 Creatine prodrugs, compositions and uses thereof
12/06/2007US20070281995 Creatine analog prodrugs, compositions and uses thereof
12/06/2007CA2653662A1 Spirocyclic nitriles as protease inhibitors
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352814C Preparation of cyclohexene carboxylate derivatives
12/05/2007CN100352813C Vinylene carbonate preparation method
12/04/2007US7304185 Reacting a diol with bromine in the presence of a trivalent bismuth compound and a base of an alkali metal carbonate or alkali metal hydroxide, to form carbonyl compounds
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
12/04/2007CA2193097C Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
11/2007
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007US20070276146 Adenine modified silica-based catalyst, a process for the preparation and use there for the production of cyclic carbonates
11/29/2007US20070276142 Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007CA2651732A1 Intracellular kinase inhibitors
11/29/2007CA2651598A1 Compounds for the treatment of metabolic disorders
11/28/2007CN101080382A Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
11/28/2007CN101079503A Organic electrolytic solution and lithium battery using the same
11/28/2007CN100351244C Bis-aromatic alkanols
11/27/2007CA2199624C Polymerizable aromatic carboxylic acids and carboxyanhydrides with cyclic carbonate groups, as well as preparations containing these compounds
11/22/2007WO2007131446A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/21/2007EP1856217A1 Energy-curable coating compositions
11/21/2007EP1856216A1 Sprayable coating composition
11/21/2007EP1856075A1 Substituted arylamine compounds and their use as 5-ht6 modulators
11/21/2007EP1546126B1 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN100349882C Method for preparing derivatives of baccatin iii
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007CA2260926C Illudin analogs useful as antitumor agents
11/20/2007CA2140382C Vitamin d compounds and method of preparing these compounds
11/15/2007WO2007131153A2 Methods for the preparation of pyrazole-containing compounds
11/15/2007WO2007129960A2 Novel processes for preparing intermediates of ccr antagonists
11/15/2007WO2007074091A3 Epoxide intermediate in the tamiflu synthesis
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070265248 Substituted piperazines and methods of use
11/14/2007EP1658279B1 Process for the preparation of propylene carbonate
11/14/2007CN101070314A Process for preparing high-purity deoxyschizandrin
11/14/2007CN101070313A Process for preparing high-purity deoxyschizandrin
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007US20070259951 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-[(3-methyl-4'-trifluoromethyl)-4-biphenylyl]methanesulfonamide
11/08/2007US20070259948 Compounds with antifungal properties and process thereof
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/07/2007EP1851193A1 Hiv protease inhibitors
11/07/2007CN101068802A Dioxole tricyclic compounds and their use as fragrances
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068476A Use of diacetyl trimer as an aromatic and flavouring substance
11/07/2007CN101066965A Prepn process of fluoric cyclic carbonate
11/07/2007CN100347166C Process for producing trifluoromethyl- substituted 2- alkoxyacetophenone derivatives
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346768C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/06/2007US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 183